Patent Assignment
Reel/Frame 050900/0268
Assignment of Assignor's Interest
Recorded: 2019-10-31
Pages: 49
Assignor
SARCODE BIOSCIENCE INC.
Executed: 2019-07-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(70)
Modulators of Cellular Adhesion
Compositions and Methods for Treatment of Eye Disorders
Modulators of Cellular Adhesion
Modulators of Cellular Adhesion
Compositions and methods for treatment of diabetic retinopathy
Application:
12/288,330 →
Publication:
US 2009/0155176
Delivery of LFA-1 antagonists to the gastrointestinal system
Application:
12/386,347 →
Publication:
US 2009/0258069
Topical LFA-1 antagonists for use in localized treatment of immune related disorders
Application:
12/386,359 →
Publication:
US 2009/0258070
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
Application:
12/386,363 →
Publication:
US 2009/0257957
Compositions and Methods for Treatment of Eye Disorders
Application:
12/508,311 →
Publication:
US 2010/0092541
Compositions and Methods for Treatment of Eye Disorders
Modulators of Cellular Adhesion
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Compositions and Methods for Treatment
Compositions and Methods for Treatment
Modulators of Cellular Adhesion
Modulators of Cellular Adhesion
Modulators of Cellular Adhesion
Application:
13/223,557 →
Publication:
US 2012/0035154
PAT058652-Us-Cnt
Compositions and Methods for Treatment of Eye Disorders
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Aerosolized Lfa-1 Antagonists for Use in Localized Treatment of Immune Related Disorders
Application:
13/960,915 →
Publication:
US 2014/0079784
Topical Lfa-1 Antagonists for Use in Localized Treatment of Immune Related Disorders
Application:
13/961,117 →
Publication:
US 2014/0051722
Compositions and Methods for Treatment
Application:
13/962,369 →
Publication:
US 2014/0073666
Compositions and Methods for Treatment
Application:
13/962,440 →
Publication:
US 2014/0099387
Modulators of Cellular Adhesion
Modulators of Cellular Adhesion
Compositions and Methods for Treatment
Compositions and Methods for Treatment
Compositions and Methods for Treatment
Compositions and Methods for Treatment
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Compositions and Methods for Treatment
Application:
14/609,743 →
Publication:
US 2015/0140075
Compositions and Methods for Treatment
Application:
14/609,770 →
Publication:
US 2015/0140076
Compositions and Methods for Treatment
Application:
14/609,795 →
Publication:
US 2015/0216857
Compositions and Methods for Treatment
Application:
14/609,967 →
Publication:
US 2015/0182520
Compositions and Methods for Treatment
Application:
14/609,998 →
Publication:
US 2015/0140077
Compositions and Methods for Treatment
Application:
14/610,043 →
Publication:
US 2015/0140078
Compositions and Methods for Treatment
Application:
14/610,182 →
Publication:
US 2015/0140079
Compositions and Methods for Treatment
Application:
14/610,251 →
Publication:
US 2015/0152090
Compositions and Methods for Treatment
Application:
14/610,291 →
Publication:
US 2015/0140080
Compositions and Methods for Treatment
Application:
14/610,318 →
Publication:
US 2015/0175577
Compositions and Methods for Treatment
Application:
14/610,338 →
Publication:
US 2015/0140081
Compositions and Methods for Treatment
Application:
14/610,346 →
Publication:
US 2015/0175578
Compositions and Methods for Treatment
Application:
14/610,370 →
Publication:
US 2015/0175579
Compositions and Methods for Treatment
Application:
14/610,401 →
Publication:
US 2015/0140082
Compositions and Methods for Treatment
Application:
14/610,414 →
Publication:
US 2015/0175580
Compositions and Methods for Treatment
Application:
14/610,464 →
Publication:
US 2015/0174119
Compositions and Methods for Treatment
Application:
14/610,465 →
Publication:
US 2015/0175581
Lfa-1 Inhibitor Formulations
Compositions and Methods for Treatment of Diabetic Retinopathy
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Continuous Flow Carboxylation Reaction
Modulators of Cellular Adhesion
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Compositions and Methods for Treatment
Application:
15/357,237 →
Publication:
US 2017/0143690
Compositions and Methods for Treatment
Application:
15/364,935 →
Publication:
US 2017/0143691
Compositions and Methods for Treatment
Application:
15/372,863 →
Publication:
US 2017/0143692
Compositions and Methods for Treatment
Application:
15/373,604 →
Publication:
US 2017/0143693
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Continuous Flow Carboxylation Reaction
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Application:
15/882,543 →
Publication:
US 2018/0251452
Modulators of Cellular Adhesion
Application:
16/172,197 →
Publication:
US 2019/0134022
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Continuous Flow Carboxylation Reaction
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Application:
16/411,598 →
Publication:
US 2020/0087287
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 21, 2006
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 018155/0742 →
Merger
Oct 25, 2007
From: SARCODE, A CALIFORNIA CORPORATION
To: SARCODE CORPORATION, A DELAWARE CORPORATION
Reel/Frame 020015/0331 →
Correction to Assignee Recorded on Reel 018155 Frame 0742
Dec 5, 2007
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE
Reel/Frame 020217/0751 →
Assignment of Assignor's Interest
Oct 13, 2010
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 025134/0277 →
Assignment of Assignor's Interest
Oct 13, 2010
From: ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025134/0219 →
Assignment of Assignor's Interest
Oct 15, 2010
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 025147/0333 →
Assignment of Assignor's Interest
Oct 15, 2010
From: SHEN, WANG; OSLOB, JOHAN D.; BARR, KENNETH
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025145/0668 →
Assignment of Assignor's Interest
Oct 22, 2010
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 025184/0125 →
Assignment of Assignor's Interest
Jan 24, 2011
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 025684/0441 →
Assignment of Assignor's Interest
Jan 24, 2011
From: ZHONG, MIN; SHEN, WANG; OSLOB, JOHAN D.; BARR, KENNETH
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025685/0952 →
Assignment of Assignor's Interest
Jan 24, 2011
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 025686/0084 →
Assignment of Assignor's Interest
Mar 29, 2011
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 026043/0842 →
Assignment of Assignor's Interest
Mar 29, 2011
From: ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 026043/0509 →
Change of Name
Sep 8, 2011
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 026876/0312 →
Security Agreement
Feb 8, 2013
From: SARCODE BIOSCIENCE INC.
To: SILICON VALLEY BANK
Reel/Frame 029778/0888 →
Merger
Feb 13, 2013
From: SARCODE, A CALIFORNIA CORPORATION
To: SARCODE CORPORATION, A CORPORATION OF STATE OF DELAWARE
Reel/Frame 029804/0051 →
Release of Security Interest
Apr 25, 2013
From: SILICON VALLEY BANK
To: SARCODE BIOSCIENCE INC.
Reel/Frame 030295/0028 →
Assignment of Assignor's Interest
Oct 22, 2020
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 054135/0165 →
Assignment of Assignor's Interest
Oct 22, 2020
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 054134/0708 →
Assignment of Assignor's Interest
Dec 6, 2023
From: NOVARTIS PHARMACEUTICALS CORPORATION
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065789/0853 →
Intellectual Property Security Agreement
Mar 27, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A.
Reel/Frame 070660/0095 →
Intellectual Property Security Agreement
Mar 28, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 070671/0627 →
Patent Security Agreement
Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
Assignment of Security Interest in Patents Previously Recorded at Reel/Frame (070660/0095)
Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072486/0740 →
Intellectual Property Security Agreement
Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0682 →